Microsurgical Instruments Market worth $2.2 billion by 2024
The microsurgical instruments market is estimated to grow from USD 1.7 billion in 2019 to USD 2.2 billion by 2024, at a CAGR of 5.2%.
(firmenpresse) - The report "Microsurgical Instruments Market by Type (Operating Microscopes, Micro Sutures (Non-Absorbable & Absorbable), Forceps, Needle Holder), Microsurgery (Plastic, Ophthal, ENT, Orthopedic, GYN), End User (Hospitals, ASCs, Academia) - Global Forecast to 2024", is projected to reach USD 2.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 5.2% during the forecast period.
The adoption of microsurgical instruments is growing across major regions majorly due to the benefits of microsurgeries over traditional surgeries; the increasing number of surgeries among the geriatric population & growing popularity of plastic and reconstructive surgeries; and the increasing prevalence of chronic diseases, lifestyle disorders, and cancer.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=53685293
The plastic & reconstructive microsurgeries segment accounted for the largest share of the microsurgical instruments market, by microsurgery type, in 2018
On the basis of microsurgery type, the microsurgical instruments market is segmented into orthopedic, neurological, ENT, ophthalmic, dental, gynecological & urological, plastic & reconstructive, and other microsurgeries. Among these, the plastic & reconstructive microsurgeries segment accounted for the largest share of the microsurgical instruments market in 2018. Increasing awareness about cosmetic procedures, coupled with growing disposable incomes, is a major factor driving the demand for cosmetic treatments via microsurgeries. Additionally, the significant growth in the number of cosmetic and reconstructive microsurgeries performed and the extensive use of microsurgical instruments in plastic & reconstructive surgeries are also expected to support market growth in the coming years.
The operating microscopes segment is expected to register the highest growth in the microsurgical instruments market, by type, during the forecast period
On the basis of type, the microsurgical instruments market is segmented into micro forceps, micro scissors, microsurgery needle holders, micro sutures, operating microscopes, and other microsurgical instruments. The operating microscopes segment is expected to register the highest growth during the forecast period. The increasing number of ophthalmic surgeries performed have driven the adoption of operating microscopes as these are commonly used in glaucoma and cataract procedures.
North America dominates the microsurgical instruments market
North America accounted for the largest share of the microsurgical instruments market in 2018. The large share of this region is attributed to the large patient pool, rising geriatric population, increasing preference for minimally invasive surgeries, growing demand for surgical/operating microscopes, increase in healthcare expenditure, and growing awareness of microsurgical techniques among surgeons.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=53685293
B. Braun Melsungen AG (Germany), ZEISS International (Germany), Danaher Corporation (US), Olympus Corporation (Japan), Novartis AG (Switzerland), Karl Kaps GmbH & Co. KG (Germany), Scanlan International (US), Topcon Corporation (Japan), Global Surgical Corporation (US), Haag-Streit Surgical (Germany), Accurate Surgical & Scientific Instruments (US), and Stille (Sweden) are some of the key players in the microsurgical instruments market.Weitere Infos zu dieser Pressemeldung:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 16.08.2019 - 10:59 Uhr
Sprache: Deutsch
News-ID 1745425
Anzahl Zeichen: 3724
Kontakt-Informationen:
Ansprechpartner: Dheeraj Shaha
Stadt:
Northbrook
Telefon: 18886006441
Kategorie:
Gesundheitswesen - Medizin
Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 16.08.2019
Diese Pressemitteilung wurde bisher 594 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Microsurgical Instruments Market worth $2.2 billion by 2024"
steht unter der journalistisch-redaktionellen Verantwortung von
MnM (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
The growth of this market is mainly driven by factors such as the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases. The report "Microplate Systems Market by Product (Microplate R
3D Cell Culture Market : Regenerative Medicine to Offer Global Growth In Coming Years ...
A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private
Immuno Oncology Assays : Research Application Transforming the Industrial Business ...
What the Immuno Oncology Assays Market looks like? Growth in Immuno Oncology Assays Market is largely driven by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. According to the new market research report "Immuno Onco
Weitere Mitteilungen von MnM
Mit Natur-Therapie, Intuitivem Bogenschießen & Gesichterlesen Life-Balance finden und Resilienz stärken. ...
Das Unternehmen im dialog - Natur*Kraft*Wege, vertreten durch Nicole Sach (Psychotherapeutische Heilpraktikerin), begleitet nun schon seit 1995 Menschen bei ihrer persönlichen Entwicklung. Durch Coaching, Beratung, Therapie und Intuitivem Bogenschießen werden Menschen sehr individuell in der Natur
Kommunikationschefin Julia Richter verlässt den BPI ...
Julia Richter, Leiterin Kommunikation, Pressesprecherin und Mitglied der Geschäftsleitung verlässt den Bundesverband der Pharmazeutischen Industrie e.V. (BPI) zum 31. August 2019. Sie hat sich zu einer beruflichen Veränderung entschlossen und geht im beiderseitigen Einvernehmen. Dr. Kai J
Pro Generika zum GSAV: "Gegen Lieferengpässe tut das neue Gesetz nichts" ...
Heute tritt das Gesetz für mehr Sicherheit in der Arzneimittelversorgung (GSAV) in Kraft - und zwar zu einem Zeitpunkt, an dem die Meldungen über Lieferengpässe beim BfArm ihren Höchststand erreichen. Nach Einschätzung des Branchenverbandes Pro Generika wird das GSAV die Versorgungssicherheit
Xinhua Silk Road: Tasly kann sich als Chinas National Tech Innovation Demonstration Enterprise für 2019 behaupten ...
Die Tasly Holding Group, eines der führenden Pharmaunternehmen Chinas, hat sich kürzlich dank ihrer kontinuierlichen Innovationen in den letzten Jahren in einem Bewertungsverfahren als Chinas National Technology Innovation Demonstration Enterprise für 2019 behaupten können. Tasly hat die
